---
mi_id: MIPR-node_5dea5fa
type: press_release
canonical_url: "https://www.pheonixresearch.com/healthcare/medical-devices/press-release/histopathology-digital-pathology-four-points-of-share/"
md_url: "https://www.pheonixresearch.com/healthcare/medical-devices/press-release/histopathology-digital-pathology-four-points-of-share.md"

schema:
  "@type": NewsArticle
  "@id": MIPR-node_5dea5fa
  url: "https://www.pheonixresearch.com/healthcare/medical-devices/press-release/histopathology-digital-pathology-four-points-of-share/"
  title: "Pheonix Research Releases 2026–2033 Histopathology Forecast: Digital Pathology Grows 1.59 Times Faster and Still Takes Only Four Points of Share"
  description: "Pheonix Research models histopathology at USD 17.80bn in 2025 to USD 31.95bn in 2033 at 7.60%; digital pathology grows 1.59x faster and takes 4.10 points of share."
  datePublished: "2026-07-03T07:03:51+00:00"
  dateModified: "2026-11-18T18:42:19+00:00"
  keywords:
    - histopathology market
    - digital pathology market
    - tissue diagnostics
    - pathology AI
    - histopathology forecast 2033
    - cancer diagnostics market
  isPartOf:
    - id: MISG-node_f29f33b
      type: CollectionPage
      url: "https://www.pheonixresearch.com/healthcare/medical-devices/"
      name: Medical Devices
    - id: MIIN-node_50b4dbf
      type: CollectionPage
      url: "https://www.pheonixresearch.com/healthcare/"
      name: Healthcare
    - id: MIWS-root
      type: WebSite
      url: "https://www.pheonixresearch.com/"
      name: Pheonix Research

acf:
  phoenix_meta_title: Digital Pathology Takes Four Points of Share in Eight Years
  phoenix_meta_description: "Pheonix Research models histopathology at USD 17.80bn in 2025 to USD 31.95bn in 2033 at 7.60%; digital pathology grows 1.59x faster and takes 4.10 points of share."

global_schema:
  organization:
    "@id": MIWS-root#organization
    "@type": Organization
    url: "https://www.pheonixresearch.com/"
    name: Pheonix Research
  website:
    "@id": MIWS-root
    "@type": WebSite
    url: "https://www.pheonixresearch.com/"
    name: Pheonix Research
  api:
    "@id": MIWS-root#api
    "@type": WebAPI
    url: "https://www.pheonixresearch.com/"

graph:
  node_id: MIPR-node_5dea5fa
  graph_node_endpoint: "https://graph.pheonixresearch.com/api/v1/query/live/node/MIPR-node_5dea5fa"
  graph_snapshot: "https://graph.pheonixresearch.com/api/v1/read/live/graph"
  graph_exclusions: "https://graph.pheonixresearch.com/api/v1/read/live/exclusions"
  graph_meta: "https://graph.pheonixresearch.com/api/v1/read/live/meta"
  graph_bundle: "https://graph.pheonixresearch.com/api/v1/read/live/bundle"

discovery:
  discovery_json: "https://www.pheonixresearch.com/.well-known/pheonix-discovery.json"
  llms_txt: "https://www.pheonixresearch.com/llms.txt"
  sitemap: "https://www.pheonixresearch.com/sitemap.xml"
---
# Pheonix Research Releases 2026–2033 Histopathology Forecast: Digital Pathology Grows 1.59 Times Faster and Still Takes Only Four Points of Share

## FOR IMMEDIATE RELEASE

**18 November 2026** — Pheonix Research has published its 2026–2033 forecast for the global histopathology market, modelling **USD 17.80 billion in 2025 rising to USD 31.95 billion in 2033**: a compound annual growth rate of 7.60 per cent and 1.79 times the base year.

The digitisation of the slide is the part of that market everyone assumes is about to change the market’s shape. On Pheonix’s numbers it does not. Digital pathology is modelled at USD 1.90 billion in 2025 rising to USD 4.72 billion in 2033 at **12.06 per cent** — **1.59 times** the rate of the total. Applied to those bases, digital pathology’s share of histopathology value moves from **10.67 per cent to 14.77 per cent**: **4.10 points of share in eight years**, on a technology growing nearly twice as fast as its parent market.

“The scanner is not the constraint, which is why the share line moves so slowly even at a 12 per cent rate,” said Pheonix Research’s healthcare and medical devices research team. “A glass slide that becomes a file changes the cost of storing and moving a specimen. It does not by itself change what a pathologist is paid to decide, and until the workflow around the diagnosis is repriced the digital layer can grow at twice the market rate and still be a minority of it in 2033.”

### Key findings

- Histopathology: USD 17.80 billion in 2025 to USD 31.95 billion in 2033 — 7.60 per cent CAGR, 1.79 times the base year.

- Digital pathology, the digitised layer inside it: USD 1.90 billion to USD 4.72 billion — 12.06 per cent CAGR.

- Growth multiple: digital pathology compounds at 1.59 times histopathology.

- Share of histopathology value: 10.67 per cent to 14.77 per cent — 4.10 points across eight years.

- Nine tier-one players are profiled, including Roche Diagnostics and Danaher. The demand drivers the report identifies are the cancer burden, tissue-based diagnosis, laboratory automation and companion diagnostics.

- This edition publishes no unit series and no slide or case volumes. It is a value model.

“Read the two numbers together and the strategic question sharpens,” the team added. “A vendor selling into the digital layer is selling a category growing at 12 per cent into a market growing at 7.6 — genuinely faster, and still a fifth of the market by 2033. That is a good business and it is not a land grab, and the difference matters to anyone underwriting capacity, a scanner fleet or a multiple on that growth.”

### The assumption that carries the forecast

The comparison rests on two Pheonix value models built on the same 2025 base and the same 2033 horizon; the share line is one divided by the other. If histopathology compounded at 6.0 per cent rather than 7.60 per cent, 2033 would be **USD 28.37 billion** instead of USD 31.95 billion. The claim the forecast actually makes is about mix inside pathology, not about test volumes — and the mix moves slowly.

### Report details

- Title: Global Histopathology Market Report, Size & Forecast 2026-2033

- Base year: 2025  ·  Forecast horizon: to 2033

- Coverage: global

- Chapters: Table of Contents, Competitive Landscape, Value Chain, Investment Activity, Technology & Innovation, Market Risk, Regulatory Landscape

- Availability: Global Histopathology Market Report 2026-2033

### About Pheonix Research

Pheonix Research publishes market intelligence on a live graph of more than 500 market, segment, industry, company and press-release nodes, translating market signals into role-specific decisions for procurement, strategy and executive teams. Each market report is modelled on stated assumptions and publishes the assumption that carries its forecast.

### Media contact

Media and research enquiries: **research@pheonixresearch.com**

Commercial and licensing: **sales@pheonixresearch.com**

*— Ends —*
